#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13820	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2323	712.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1440	1440	C	831	C,G	828,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13820	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2323	712.6	0	HET	.	.	.	T1412TGGGGG,TGGGGGG	.	1412	1412	T	1668	1668	T	907	TGGGGG,TGGGGGG	641,193	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	13820	16S	1529	1529	100.0	16S.l15.c17.ctg.1	2323	712.6	0	HET	.	.	.	C1525T	.	1525	1525	C	1781	1781	C	789	C,T	588,201	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24100	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4025	745.6	0	.	n	.	0	T695C	SNP	695	695	T	1228	1228	C	870	C,T	869,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24100	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4025	745.6	0	.	n	.	0	A1638G	SNP	1638	1638	A	2171	2171	G	850	G,A,T	846,2,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24100	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4025	745.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2504	2504	C	868	C,T	866,2	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24100	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4025	745.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2578	2578	A	816	A,G,C	813,2,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	24100	23S	2890	2890	99.9	23S.l6.c4.ctg.1	4025	745.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	3130	3130	C	820	C,G,A	818,1,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2116	folP	855	855	100.0	folP.l15.c4.ctg.1	2005	131.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1244	1246	AGC	203;202;203	A;G;C	203;202;203	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5020	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3981	157.1	1	SNP	p	S91F	1	.	.	271	273	TTC	864	866	TTC	187;184;184	T,G;T;C	186,1;184;184	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5020	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3981	157.1	1	SNP	p	D95G	1	.	.	283	285	GGC	876	878	GGC	190;193;193	G;G,A;C	190;192,1;193	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5020	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3981	157.1	1	SNP	p	G95N	0	.	.	283	285	GGC	876	878	GGC	190;193;193	G;G,A;C	190;192,1;193	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1812	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1879	120.2	0	.	p	.	0	F184L	NONSYN	550	552	TTC	1132	1134	TTG	195;192;193	T,A;T;G	194,1;192;193	.	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	539	1812	mtrR	633	633	99.84	mtrR.l15.c4.ctg.1	1879	120.2	1	SNP	p	G45D	0	.	.	133	135	GGC	715	717	GGC	208;205;207	G;G;C	208;205;207	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1046	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c17.ctg.1	1584	82.2	0	.	n	.	0	A197.	DEL	197	197	A	814	814	A	201	A,T	200,1	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4806	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3446	173.8	1	SNP	p	D86N	0	.	.	256	258	GAC	811	813	GAC	208;208;208	G,A;A,T;C	207,1;207,1;208	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4806	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3446	173.8	1	SNP	p	R87W	0	.	.	259	261	CGT	814	816	CGT	209;208;209	C;G,C;T	209;207,1;209	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4806	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3446	173.8	1	SNP	p	R87I	0	.	.	259	261	CGT	814	816	CGT	209;208;209	C;G,C;T	209;207,1;209	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4806	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3446	173.8	1	SNP	p	S87R	1	.	.	259	261	CGT	814	816	CGT	209;208;209	C;G,C;T	209;207,1;209	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	4806	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3446	173.8	1	SNP	p	S88P	0	.	.	262	264	TCC	817	819	TCC	211;208;209	T;C;C,G	211;208;208,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4072	parE	1986	1986	100.0	parE.l15.c4.ctg.1	3315	153.0	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1933	1935	GGC	219;219;217	G;G;C	219;219;217	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.5.002	penA.5.002	1	1	27	3836	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2889	165.5	1	SNP	p	A311V	0	.	.	931	933	GCA	1511	1513	GCA	225;227;226	G;C;A	225;227;226	penA.5.002:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3836	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2889	165.5	1	SNP	p	I312M	0	.	.	934	936	ATC	1514	1516	ATC	225;224;225	A;T;C,T,G	225;224;222,1,2	penA.5.002:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3836	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2889	165.5	1	SNP	p	V316P	0	.	.	946	948	GTG	1526	1528	GTG	223;225;227	G;T,C;G	222;224,1;227	penA.5.002:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3836	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2889	165.5	1	SNP	p	V316T	0	.	.	946	948	GTG	1526	1528	GTG	223;225;227	G;T,C;G	222;224,1;227	penA.5.002:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3836	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2889	165.5	1	SNP	p	T484S	0	.	.	1450	1452	ACC	2030	2032	ACC	240;241;241	A,G;C;C,G	239,1;241;240,1	penA.5.002:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3836	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2889	165.5	1	SNP	p	A502V	0	.	.	1504	1506	GCG	2084	2086	GCG	229;223;222	G;C;G	229;223;222	penA.5.002:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3836	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2889	165.5	1	SNP	p	A502P	0	.	.	1504	1506	GCG	2084	2086	GCG	229;223;222	G;C;G	229;223;222	penA.5.002:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3836	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2889	165.5	1	SNP	p	G543S	1	.	.	1627	1629	AGC	2207	2209	AGC	195;195;195	A;G,T;C	195;194,1;195	penA.5.002:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3836	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2889	165.5	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2216	2218	GGC	202;204;204	G;G,T;C	202;203,1;204	penA.5.002:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.5.002	penA.5.002	1	1	27	3836	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2889	165.5	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2234	2236	CCG	222;222;220	C;C;G	222;222;220	penA.5.002:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5248	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3620	180.6	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1927	1929	CCG	202;200;201	C,A;C,G,A;G,T	201,1;198,1,1;200,1	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2300	porA	1146	1146	99.91	porA.l6.c30.ctg.1	2393	119.6	0	.	p	.	0	M83fs	FSHIFT	247	247	A	856	856	C	173	C	173	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	286	porB1a	984	112	91.96	porB1a.l15.c17.ctg.2	215	48.8	0	.	p	.	0	M18T	NONSYN	52	54	ATG	133	135	ACG	69;68;64	A;C;G	68;68;63	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	286	porB1a	984	112	91.96	porB1a.l15.c17.ctg.2	215	48.8	0	.	p	.	0	E32Q	NONSYN	94	96	GAA	175	177	CAA	14;12;12	C;A;A	14;12;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	286	porB1a	984	112	91.96	porB1a.l15.c17.ctg.2	215	48.8	0	.	p	.	0	S34Y	NONSYN	100	102	TCC	181	183	TAC	4;2;1	T;A;C	4;2;1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	286	porB1a	984	156	92.95	porB1a.l15.c17.ctg.3	156	43.3	0	.	p	.	0	V258L	NONSYN	772	774	GTA	14	16	TTA	23;23;24	T;T;A	23;23;24	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	286	porB1a	984	156	92.95	porB1a.l15.c17.ctg.3	156	43.3	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	59	61	CAT	54;54;54	C;A;T	54;54;54	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	286	porB1a	984	156	92.95	porB1a.l15.c17.ctg.3	156	43.3	0	.	p	.	0	D274S	NONSYN	820	822	GAT	62	64	AGT	54;54;54	A;G;T	54;54;54	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	512	286	porB1a	984	156	92.95	porB1a.l15.c17.ctg.3	156	43.3	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	71	73	TAC	54;54;54	T;A;C,T	54;54;53,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2694	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1931	173.1	0	.	p	.	0	N38E	NONSYN	112	114	AAT	585	587	GAA	228;229;229	G;A,T,C;A,C	228;227,1,1;228,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2694	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1931	173.1	0	.	p	.	0	N134D	NONSYN	400	402	AAT	873	875	GAT	248;245;246	G;A,T;T	248;244,1;246	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2694	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1931	173.1	0	.	p	.	0	P175S	NONSYN	523	525	CCA	996	998	TCA	244;250;252	T,C,A;C,G,A;A,G,C	242,1,1;248,1,1;250,1,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2694	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1931	173.1	0	.	p	.	0	A218V	NONSYN	652	654	GCC	1125	1127	GTC	213;215;216	G;T,G;C,T	213;214,1;215,1	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2694	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1931	173.1	0	.	p	.	0	F222S	NONSYN	664	666	TTT	1137	1139	TCT	215;215;217	T,G;C;T	214,1;215;217	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2694	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1931	173.1	0	.	p	.	0	E328A	NONSYN	982	984	GAA	1455	1457	GCA	214;215;213	G;C;A	214;215;213	.	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2694	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1931	173.1	1	SNP	p	G120K	1	.	.	358	360	AAG	831	833	AAG	224;223;223	A,G;A;G	222,1;223;223	porB1b.WHO_V_02265c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2694	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1931	173.1	1	SNP	p	A121D	1	.	.	361	363	GAC	834	836	GAC	225;226;225	G,T,C;A,G;C	223,1,1;225,1;225	porB1b.WHO_V_02265c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_V_02265c	porB1b.WHO_V_02265c	1	1	539	2694	porB1b	1047	1047	99.14	porB1b.l15.c30.ctg.1	1931	173.1	1	SNP	p	D121N	0	.	.	361	363	GAC	834	836	GAC	225;226;225	G,T,C;A,G;C	223,1,1;225,1;225	porB1b.WHO_V_02265c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	9110	rpoB	4179	4179	99.98	rpoB.l6.c17.ctg.1	5296	214.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1396	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1460	119.0	1	SNP	p	V57M	1	.	.	169	171	ATG	719	721	ATG	227;229;226	A,C;T;G	226,1;229;226	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
